First, by addressing prior studies that suggest that changes in tumor-associated ECM are necessary for TGFβ-dependent myofibroblastic activation (Desmoulière et al., 1993; Serini et al., 1998), they dissect the interaction of TGFβ with N-ECM versus D-ECM. This evidence concerns the gene TGFB1 and neoplasm.